Form CORRESP - Correspondence:
SEC Accession No. 0001144204-19-017731
Filing Date
2019-04-02
Accepted
2019-04-02 16:30:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6286
  Complete submission text file 0001144204-19-017731.txt   7249
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

EIN.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)